IGFBP4 antibody (C-Term)

Catalog No. ABIN263196

This anti-IGFBP4 antibody is a Goat Polyclonal antibody detecting IGFBP4 in WB and ELISA. Suitable for Human.

Quick Overview for IGFBP4 antibody (C-Term) (ABIN263196)

Target: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This IGFBP4 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Grade: Verified

Product Details anti-IGFBP4 Antibody

Binding Specificity: C-Term

Purpose: IGFBP4

Sequence: KGELDCHQLA DSFRE

Cross-Reactivity: Cow, Human, Mouse

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Immunogen: Peptide with sequence KGELDCHQLADSFRE, from the C Terminus of the protein sequence according to NP_001543.2.

Isotype: IgG

Application Details

Application Notes:

Western Blot: Approx 30 kDa band observed in Human Liver lysates (calculated MW of 27.9 kDa according to NP_001543.2). Recommended concentration: 1-3 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:8000.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Minimize freezing and thawing.

Storage: -20 °C

Storage Comment: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Target Details for IGFBP4

Target: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Alternative Name: IGFBP4

Background: IGFBP4 , insulin-like growth factor binding protein 4 , BP-4, HT29-IGFBP, IBP4, IGFBP-4, IGF-binding protein 4, insulin-like growth factor-binding protein 4

Gene ID: 3487

NCBI Accession: NP_001543

Pathways: WNT Signaling, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process